[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.171.35. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Commentary
July 8, 2009

Possible Outcomes of Comparative Effectiveness Research

Author Affiliations

Author Affiliation: RAND Corporation, Santa Monica, California, and School of Public Health, David Geffen School of Medicine, University of California, Los Angeles.

JAMA. 2009;302(2):194-195. doi:10.1001/jama.2009.996

With substantial support across the political spectrum, the Obama administration has included in the American Recovery and Reinvestment Act more than $1 billion to support comparative effectiveness research.1 At the same time, the president has demanded reforms in the US health care system to make health care more affordable for all US citizens.2 This Commentary focuses on the interaction of these 2 initiatives: what will be the cost effect of spending $1 billion on comparative effectiveness research?

First Page Preview View Large
First page PDF preview
First page PDF preview
×